Not applicableStudy completedNCT06268717What this trial is testingGI Alpha-Gal StudyWho this might be right forAlpha-Gal SyndromeIrritable Bowel SyndromeDiarrhea+2 more University of North Carolina, Chapel Hill 30
Testing effectiveness (Phase 2)Looking for participantsNCT07611435What this trial is testingBeginning to Assess an Appropriate CONtrol for Oral Food Challenges in Alpha-Gal Syndrome (CoFAR-13) - BeACON4AGWho this might be right forAlpha-Gal SyndromeAllergy National Institute of Allergy and Infectious Diseases (NIAID) 160
Not applicableLooking for participantsNCT07177729What this trial is testingThe α-gal Syndrome - Investigating Immune Reactions to Tick BitesWho this might be right forAlpha-Gal Syndrome Luxembourg Institute of Health 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07526558What this trial is testingMast Cell Treatment in Post-tick Bite Illness (PTBI)Who this might be right forPost-tick Bite IllnessMast Cell Stabilizer University of North Carolina, Chapel Hill 50
Not applicableUnknownNCT05635266What this trial is testingTissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesWho this might be right forAge-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more Sanguine Biosciences 20,000
Not applicableLooking for participantsNCT07143669What this trial is testingScreening Study for KIT D816V Mutated Mast Cell Disease in Select PopulationsWho this might be right forClonal Mast Cell DiseaseKIT D816V MutationSuspected KITD816V Mutated Clonal Mast Cell Disease Blueprint Medicines Corporation 750